Early Vascular Response 3 Months after Cobalt-chromium Everolimus-eluting Stent Implantation in Patients with Multivessel Coronary Artery Disease: Serial Angioscopic Observation Study-Reference-Cited by-同舟云学术

Early Vascular Response 3 Months after Cobalt-chromium Everolimus-eluting Stent Implantation in Patients with Multivessel Coronary Artery Disease: Serial Angioscopic Observation Study

Published:2019 Issue:1 Volume:5 Page:19-25
ISSN:2188-6571
Container-title:Angioscopy
language:en
Short-container-title:

Author:

KAWAI Kenji¹²,AKAHORI Hirokuni¹,IMANAKA Takahiro¹,MIKI Kojiro¹,YOSHIHARA Nagataka¹,YANAKA Koji¹,KIJIMA Yoshiyuki²,MASUYAMA Tohru²,ISHIHARA Masaharu¹

Affiliation:

1. Division of Cardiovascular Medicine, Hyogo College of Medicine

2. JCHO Hoshigaoka Medical Center

Publisher

Japanese Association of Cardioangioscopy

Link

https://www.jstage.jst.go.jp/article/angioscopy/5/1/5_oa.19.0027/_pdf

Reference19 articles.

1. 1) Kufner S, Joner M, Thannheimer A, et al: Ten-year clinical outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease. Circulation 2019; 139: 325–333

2. 2) Otsuka F, Vorpahl M, Nakano M, et al: Pathology of second-generation everolimus-eluting stents versus first generation sirolimus- and paclitaxel-eluting stents in humans. Circulation 2014; 129: 211–223

3. 3) Kandzari DE, Koolen JJ, Doros G, et al: Ultrathin bioresorbable polymer sirolimus-eluting stents versus thin durable polymer everolimus-eluting stents. J Am Coll Cardiol 2018; 72: 3287–3297

4. 4) Emond M, Mock MB, Davis KB, et al: Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 1994; 90: 2645–2657

5. 5) Lee SY, Hong MK, Shin DH, et al: Association between duration of dual antiplatelet therapy and angiographic multivessel disease on outcomes in patients treated with newer-generation drug-eluting stents. Circ Cardiovasc Interv 2016; 9: e004256